Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.73% | -139.59% | 10.61% | 97.39% | -39.57% |
| Total Depreciation and Amortization | -28.66% | -25.08% | 24.30% | 22.62% | 15.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -105.64% | 100.67% | -54.73% | -416.07% | 93.22% |
| Change in Net Operating Assets | -96.07% | 102.06% | 68.40% | 114.44% | 93.07% |
| Cash from Operations | -23.82% | 88.53% | 39.72% | 54.33% | 9.87% |
| Capital Expenditure | 94.74% | -111.11% | -- | -- | -307.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -128.09% | -- |
| Cash from Investing | -- | -101.37% | -100.00% | -101.12% | 100.00% |
| Total Debt Issued | -- | -65.39% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 95.89% | 53.11% | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -39.68% | -150.42% | 377.76% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.53% | 245.84% | -46.07% | 106.21% | 166.81% |